National Institute of Allergy and Infectious Diseases
North America, Maryland, United States, Bethesda
Description
National Institute of Allergy and Infectious is a medical research agency that supports basic and applied research for allergic diseases.
Investor Profile
National Institute of Allergy and Infectious Diseases has backed more than 116 startups, with 13 new investments in the last 12 months alone. The firm has led 102 rounds, about 88% of its total and boasts 10 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Grant, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, France.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 12 rounds in the past year.
Stage Focus
- Grant (99%)
- Series Unknown (1%)
Country Focus
- United States (99%)
- France (1%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Life Science
- Education
- Pharmaceutical
- Biopharma
- Medical Device
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
